What are the indications for initiating dialysis in acute renal failure?

Indications for Dialysis in Acute Renal Failure

Initiate renal replacement therapy emergently when life-threatening metabolic complications exist: severe hyperkalemia with ECG changes, pulmonary edema causing respiratory compromise unresponsive to diuretics, severe metabolic acidosis (pH <7.25 or bicarbonate <10 mmol/L), or uremic complications (encephalopathy, pericarditis, bleeding). 1, 2, 3

Absolute (Emergent) Indications

These require immediate dialysis initiation regardless of creatinine or urea levels:

• Severe hyperkalemia (≥6.0 mmol/L) with ECG changes or rapidly rising potassium unresponsive to medical management 2, 4, 3
• Pulmonary edema or severe fluid overload causing respiratory compromise that is refractory to diuretics 2, 4, 3
• Severe metabolic acidosis with arterial pH <7.25 or serum bicarbonate <10 mmol/L despite medical therapy 2, 4, 3
• Uremic complications including encephalopathy, pericarditis, or uremic bleeding 2, 4, 3
• Severe symptomatic dysnatremia resistant to medical management 2

Relative Indications (Delayed/Standard Approach)

In the absence of absolute indications, KDIGO and major nephrology societies recommend a delayed/standard approach rather than early preemptive dialysis, as early initiation does not improve survival and may cause harm: 1, 5

• Blood urea nitrogen >40 mmol/L (>112 mg/dL) in the context of progressive azotemia with clinical deterioration 5, 4
• KDIGO Stage 3 AKI (creatinine ≥3× baseline or ≥4.0 mg/dL with acute rise ≥0.3 mg/dL) that persists despite addressing reversible factors 1, 5, 4
• Progressive oliguria (<0.3 mL/kg/h for ≥24 hours) unresponsive to fluid optimization 1, 6
• Refractory volume overload despite maximal diuretic therapy in hemodynamically stable patients 1, 2

Critical Decision-Making Framework

Step 1: Rule Out Absolute Indications

Check potassium, arterial blood gas, assess for pulmonary edema and uremic symptoms. If any absolute indication is present, initiate dialysis immediately. 2, 3

Step 2: Optimize Reversible Factors

• Discontinue all nephrotoxic medications (NSAIDs, ACE-I/ARBs, diuretics, aminoglycosides) 6, 3
• Ensure adequate volume resuscitation with isotonic crystalloids if hypovolemic 6, 3
• Rule out urinary obstruction with renal ultrasound 6, 3
• Treat underlying infection aggressively 6

Step 3: Monitor Trajectory

• Repeat creatinine and electrolytes every 4-6 hours in Stage 2-3 AKI 6
• Assess trends rather than single values—rising azotemia with clinical deterioration warrants earlier intervention 7, 8
• Monitor urine output as the most robust predictor of need for RRT 5

Step 4: Apply Delayed Initiation Criteria

If no absolute indications exist and reversible factors are addressed, delay dialysis until: 5

• BUN exceeds 40 mmol/L (112 mg/dL) with clinical deterioration 5
• Stage 3 AKI persists >48 hours despite optimal management 1, 6
• Metabolic demands exceed renal capacity based on overall clinical trajectory 1

Modality Selection

• Continuous RRT (CRRT) is preferred for hemodynamically unstable patients requiring vasopressors, those with acute brain injury/increased intracranial pressure, or severe fluid overload 1, 2
• Intermittent hemodialysis may be used for rapid correction of severe hyperkalemia in hemodynamically stable patients 2
• Deliver effluent volume of 20-25 mL/kg/h for CRRT 1, 2
• Use bicarbonate-based replacement fluids in shock, liver failure, or lactic acidosis 2

Common Pitfalls to Avoid

• Do not initiate dialysis based solely on creatinine or BUN thresholds in asymptomatic patients—this "early" strategy increases mortality without benefit 5, 4, 7
• Do not delay dialysis when absolute indications exist—presence of traditional indications at dialysis initiation is associated with 6.5-fold higher mortality 4
• Do not use eGFR equations during acute changes; they require steady-state creatinine and are inaccurate in AKI 6, 9
• Do not assume renal recovery based on creatinine normalization during dialysis—true recovery requires sustained independence from RRT for ≥14 days 2

Special Populations

Cirrhosis with AKI

• Administer albumin 1 g/kg/day (max 100 g) for 2 days if creatinine doubles 6
• For hepatorenal syndrome, add vasoactive therapy (terlipressin or norepinephrine) with albumin 6
• Hold diuretics and β-blockers immediately 6

Hemodynamically Unstable Patients

• CRRT is physiologically superior to intermittent hemodialysis, though RCTs show no survival difference 1
• Avoid excessive fluid removal that causes hypotension and impedes renal recovery 2